Division of Pharmaceutical Technology and Biopharmacy
Division of Pharmaceutical Technology and Biopharmacy
Prof. Dr. Dagmar Fischer
The Fischer group is focussed on the development of natural and synthetic micro- and nanocarriers for drug delivery in the field of infection, inflammation and inflammation-related diseases as well as aging. A major focus is related to biopharmaceutical test systems according to the 3R principle to investigate the life cycle of drug delivery systems and the influence of the physiological environment. Furthermore, nanosafety and safe-by-design concepts as well as quality assurance concepts are provided
News
Johanna Herzog presented her research at the PDA Good Aseptic Manufacturing Conference 2025 in Basel
SMARTIES Status Meeting at 25 and 26 May 2025 at FAU
Talk Vincent Lau from HIRI Würzburg
Beilstein Talk Prof. Dagmar Fischer
Kick-off for the network for therapeutic nucleic acids
24.04.2025 DPhG Vortrag “Cyanobakterien – eine spannende, aber wenig untersuchte Quelle biologisch aktiver Naturstoffe”
SMARTIES – Our new project funded by ZIM
Prof. Fischer talks at the IoBNT Project Meeting
Tom Bellmann successfully defended his thesis
Workshop „Rezeptur für ausländische Apotheker“ with Dr. Stefan Seyferth and Dr. Andreas Ziegler at LPTB
Tatjana Nikitina, VA
Sekretärin
Cauerstraße 4 (Haus 6)
91058 Erlangen
Cauerstraße 4 (Haus 6)
91058 Erlangen
- Phone number: +49 9131 85-29551
- Email: tatjana.nikitina@fau.de
- Website: http://www.pharmtech.uni-erlangen.de